A rating of 79 puts Celldex Therapeutics, Inc. (CLDX) near the top of the Biotechnology industry according to InvestorsObserver. Celldex Therapeutics, Inc.'s score of 79 means it scores higher than 79% of stocks in the industry. Celldex Therapeutics, Inc. also received an overall rating of 62, putting it above 62% of all stocks. Biotechnology is ranked 46 out of the 148 industries.
CLDX has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on CLDX!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Celldex Therapeutics, Inc. Stock Today?
Celldex Therapeutics, Inc. (CLDX) stock is trading at $32.35 as of 10:32 AM on Monday, Nov 6, a gain of $6.37, or 24.5% from the previous closing price of $25.98. The stock has traded between $24.72 and $33.55 so far today. Volume today is more active than usual. So far 1,583,599 shares have traded compared to average volume of 491,943 shares.
Click Here to get the full Stock Report for Celldex Therapeutics, Inc. stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
